Close

Form 3 PLx Pharma Inc. For: Nov 18 Filed by: Hardie Robert D.

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. META
3. ENPH
4. TXN
5. BA
6. SPOT
7. IBM
8. V
9. HCP
10. KMB


March 16, 2021 3:44 PM EDT
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Level One Partners, LLC
(Last) (First) (Middle)
210 RIDGE MCINTIRE ROAD, SUITE 350
(Street)
CHARLOTTESVILLE VA 22903
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
11/18/2020 		3. Issuer Name and Ticker or Trading Symbol
PLx Pharma Inc. [ PLXP ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $0.001 par value 1,320,306 (1) (2)
D
 
Common Stock, $0.001 par value 875,000 (2)
D
 
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants (right to buy) 11/18/2020 11/18/2025 Common Stock 1,452,337 (3) 4.31 D  
Explanation of Responses:
1. Level One Partners, LLC (the "Reporting Person") is owned by Robert D. Hardie ("Mr. Hardie") and Molly G. Hardie ("Ms. Hardie"), who are married. Mr. Hardie is the manager of the Reporting Person and also holds shares of PLx Pharma Inc. (the "Company") individually.
2. As of the date of this report, the Reporting Person holds 1,320,306 shares of Common Stock, $.001 par value per share (the "Common Stock") of the Company, and Mr. Hardie holds 875,000 shares of Common Stock of the Company. Pursuant to 17 CFR Section 240.16a-1(a)(2), Ms. Hardie's beneficial ownership is limited to her pecuniary interest, if any, in such securities.
3. As of the date of this report, the Reporting Person holds warrants to purchase 1,452,337 shares of Common Stock.
Robert D. Hardie, Manager of Level One Partners, LLC 03/12/2021
** Signature of Reporting Person Date
Robert D. Hardie 03/12/2021
** Signature of Reporting Person Date
Molly G. Hardie 03/12/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings